Alejandro Lemor MD, MS

It was great to have Dr Karthik Ananth (@HenryFordHealth ) for @UMMCMedicine Grand Rounds and update us all on "Cardiovascular PET Imaging”.

📖PVAD-supported high-risk #PCI in non-shock patients may be associated with improved clinical out-comes compared with #IABP support 💡Read more ⤵️ ➡️jscai.org/article/S2772-… @AlexandraLansky @TayyabShahMD @JWMoses @AlejandroLemor @BillONeillMD #PercutaneousCoronaryIntervention #PercutaneousVentricularAssistDevice #IntraAorticBalloonPump

Very important work led by @JasmineMarquard & Danger Investigators w/ improved outcomes observed w/ MV-PCI compared to culprit vessel PCI (hypothesis generating), similar to what @AlejandroLemor showed in #NCSI. Very low rate of CTO PCI (6%), all STEMI, no comatose OHCA

Department of Medicine Grand Rounds Tuesday, September 30th at noon, Dr. Alejandro Lemor will present "Contemporary Management of Cardiogenic Shock" in R354 and WebEx umc.webex.com/umc/j.php?MTID…

🚨 New Findings from PROTECT III: focused on pt baseline characteristics & short- intermediate outcomes when treated with #Impella-supported #HRPCI. ➡️doi.org/10.1016/j.jsca… @FalahBatla @TayyabShahMD @abu_much @djc795 @BjornRedfors @SuzanneJBaron @Babar_Basir @adityadoc1 @AlejandroLemor @agtruesdell @BillONeillMD @_WayneBatchelor #HighRiskPCI #PCI #CABG

@mmamas1973 @MichaelMegalyMD @jbspadoni @PedroMDMSc @AGoldsweig @DrChuckSimonton @KhandelwalMD @KAlaswadMD @behnam_tehrani @UMMC_Heart

When patients were stratified into 2 cohorts based on HRPCI score (scores 0–4 vs. scores 5–8) 30-day mortality was significantly higher among those with scores 5–8 (5.4 % vs. 17.0 %, HR [95 % CI] = 3.4 [2.12–5.51], p < 0.0001)

Novel risk score for Impella-HRPCI to calculate in-hospital mortality. Easy to remember and can be useful to discuss risk of mortality with patients undergoing #HRPCI. 📌 sciencedirect.com/science/articl…

Wonderful work led by @ImranAziz96 @AhmadJabri8 & YingXu on flow characteristics of reperfusion sheaths w large bore MCS. No difference b/t sheath sizes (as it relates to flow), better flow w active flow vs passive. Need detected sheaths in the future. sciencedirect.com/science/articl…

Save the date! 🗓️ Join us for the Cardiogenic Shock LATAM Symposium 🫀⚡️in beautiful Cancun! An unmissable event for experts and innovators in the field. Stay tuned for more details! #CShockLATAM @TecSaludMX @GTorreAmione

📘#SCAIMCSebook Highlight: Chapter 7—Treatment Escalation Guidelines. Early intervention is critical and knowing when to escalate MCS starts with identifying worsening or undertreated #CardiogenicShock. This chapter explores escalation options, key parameters for deteriorating hemodynamics, and the role of a shock team in decision-making. It also features device options for uni- and biventricular support, along with case examples. 🔗 scaipro.scai.org/URL/MCSEbookSe… #Cardiology @Babar_Basir @AlejandroLemor, @kjkunkelmd @AdhirShroff @agtruesdell @duanepinto

Discover the foundations of #CardiogenicShock and #MCS with SCAI's newest ebook, “Short-Term Mechanical Circulatory Support for Cardiogenic Shock” 📘➡️ scaipro.scai.org/URL/MCSEbookSe… 📖 Section 1 dives into critical topics, including understanding #CS, the use of right heart catheterization for hemodynamic assessment, pharmacotherapy, treatment escalation, and the importance of specialized shock protocols and teams. #SCAIMCSebook #HeartTeamApproach #CardiologyEducation #CardioTwitter #CardioX #CardioEd @BurkhoffDaniel @ICUDocAP @kjkunkelmd @ericalanosborn @cmrosner @ShashankSinhaMD @behnam_tehrani

More “why-when MCS” for high-risk PCI: “Clinical Outcomes of Patients Experiencing Transient Loss of Pulse Pressure During High-Risk PCI with Impella”👉: 🔗 onlinejcf.com/article/S1071-……

Have you ever wondered if LOPP during HR-PCI meant anything? Interesting 1/2 of HR-PCI pts supported w/ Impella experienced LOPP. It was not benign! LOPP was associated w/ increased rates of MACCE. More to come in the Protect IV trial. @GreggWStone @duanepinto @JWMoses

Very important work on RVD in NCSI led by @SarahGorgis @krtkgpt @AlejandroLemor. RVD (defined as RA > 12, PAPI <1) was present in about ~30% of AMI-CS pts. Pts w RVD were sicker, had higher SCAI shock stage, lactate & worse mortality. @JCardFail sciencedirect.com/science/articl…

Check out the #SCAISHOCK 2024 preliminary program for a first look at some of the sessions you can attend during the conference this October 17-19 ➡️ scai.confex.com/scai/shock24/m… 📌Register now to join us in Washington, DC: scai.org/2024-scai-shoc… #CardiogenicShock #Shock

Case submission is open for SCAI Shock! Best saves, worst complications, interesting hemodynamics we want it all! @SCAI @scaielm @Allison_Dupont @SandeepNathanMD @JasonKatzMD @DrRobRoswell @agtruesdell @PerwaizMeraj

@UMMC_Heart @UMMCnews

Our analysis of patients with chronic kidney disease (first report of dialysis pts) who received Impella assisted HRPCI in Protect III @CircIntv #CirculationIntv #MedTwitter #CardioTwitter 💥Lower eGFR had more severely calcified CAD, greater atherectomy usage but no increased risk of procedural complications 💥eGFR <30/dialysis pts had higher 90 day MACE and 1 year mortality (in line with other PCI & CABG studies) 💥no statistically significant differences in outcomes between groups until eGFR<30 ahajournals.org/doi/abs/10.116… @BillONeillMD @Babar_Basir @AlexandraLansky @SuzanneJBaron @DrCindyGrines @_WayneBatchelor @abu_much